Delivery Order SPE2DB22D3004-SPE2DB25FSF82
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Abilify Maintena ER 300 mg vials/syringes with a ceiling value of $1,382.47. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The order is scheduled for completion by August 4, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,642.07 to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Abilify Maintena ER 300 mg syringes. This is a firm fixed-price delivery order with an ultimate completion date of August 29, 2025. The award was made on a competitive basis with no set-aside designation, and the place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,764.94 on July 23, 2025, for the supply of Abilify Maintena ER 300 mg vials/syringes/cartridges. This firm fixed price delivery order, with an ultimate completion date of July 24, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply framework with the federal government. The award was not designated as a set-aside contract and was competitively awarded. Performance...
- The Defense Logistics Agency awarded a delivery order valued at $1,842.17 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. This firm fixed price contract, awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a competitively awarded, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,681.49 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes, with an ultimate completion date of July 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier within...
- The Defense Logistics Agency awarded a delivery order valued at $3,684.34 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. This firm fixed-price contract, awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a non-set-aside competitive procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,842.17 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. This firm fixed price delivery order was competitively awarded without set-aside designation and is set for completion by August 13, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order falls under...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $2,046.17. The order is for Abilify Maintena ER 400 mg syringes, a medication used to treat mental health conditions. The order has a firm fixed price and a completion date of July 7, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides...
- This delivery order, valued at $2,807.89, was awarded on July 18, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. The contract employs firm fixed-price pricing and is scheduled for completion by July 21, 2025. This award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. No...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $2,714.54 for the supply of Abilify Maintena Extended-Release (ER) 400 mg syringes. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 24, 2024. The contract is a firm-fixed-price delivery order, which is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSF82Delivery Order
The Defense Logistics Agency awarded a $3,765.38 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Abilify Asimtufii 960 mg/3.2 mL injectable medication. This competitively awarded, firm fixed-price contract carries an ultimate completion date of September 2, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. As a non-set-aside procurement, this delivery order was issued under open competition, reflecting the contractor's demonstrated capability to meet federal pharmaceutical supply requirements. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support for military healthcare programs worldwide, enabling AmerisourceBergen to supply specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. The company's substantial federal contract portfolio demonstrates its role as a critical vendor within the federal medical supply chain and its ability to fulfill diverse pharmaceutical procurement needs through flexible contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 8/29/25 |